An Assessment of the Effect of Food and Antacid on BIIB021 Pharmacokinetics in Subjects With Advanced Solid Tumors.
Phase of Trial: Phase I
Latest Information Update: 05 Jun 2015
At a glance
- Drugs CNF 2024; Ranitidine
- Indications Solid tumours
- Focus Biomarker; Pharmacokinetics; Registrational
- Sponsors Biogen
- 06 Jan 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 01 May 2010 Planned number of patients changed from 16 to 20 as reported by ClinicalTrials.gov.
- 01 May 2010 Planned end date changed from 1 Sep 2010 to 1 Jan 2011 as reported by ClinicalTrials.gov.